got-1.2

Caenorhabditis elegans

Enables L-aspartate:2-oxoglutarate aminotransferase activity. Involved in positive regulation of glutamate metabolic process. Located in cytoplasm. Expressed in head; neurons; and tail. Human ortholog(s) of this gene implicated in several diseases, including amyotrophic lateral sclerosis; pancreatic ductal adenocarcinoma; and transient cerebral ischemia. Is an ortholog of human GOT1 (glutamic-oxaloacetic transaminase 1).

C15F1.14

Caenorhabditis elegans

Is affected by cep-1; adr-1; and sftb-1 based on RNA-seq studies.

C17G10.14

Caenorhabditis elegans

Is affected by adr-1; etr-1; and ogt-1 based on RNA-seq studies.

C41C4.18

Caenorhabditis elegans

Is affected by prg-1; hsf-1; and glp-1 based on RNA-seq studies.

F18C5.15

Caenorhabditis elegans

Is affected by cep-1; dlc-1; and ogt-1 based on RNA-seq studies.

F26D11.15

Caenorhabditis elegans

Is affected by cep-1; dlc-1; and glp-1 based on RNA-seq studies.

R05F9.14

Caenorhabditis elegans

Is affected by adr-1; etr-1; and ogt-1 based on RNA-seq studies.

T23F2.9

Caenorhabditis elegans

Is affected by etr-1; hpk-1; and ogt-1 based on RNA-seq studies.

Y38E10A.33

Caenorhabditis elegans

Is affected by adr-1; olrn-1; and ogt-1 based on RNA-seq studies.

ZK1037.12

Caenorhabditis elegans

Is affected by etr-1; qui-1; and ogt-1 based on RNA-seq studies.